116.[20221214]Updated management for AMR > 1분 논문읽기

본문 바로가기


연구소 자료

KOSIN UNIVERSITY COLLEGE OF MEDICINE

116.[20221214]Updated management for AMR

페이지 정보

작성자 신호식 작성일23-02-03 14:08 조회500회 댓글0건

본문

첨부한 자료(유튜브 클립, 참고문헌 등)를 학문적 목적으로만 사용해 주시길 부탁드립니다

Review Curr Opin Nephrol Hypertens
. 2023 Jan 1;32(1):13-19. doi: 10.1097/MNH.0000000000000843. Epub 2022 Oct 11.
Updated management for antibody-mediated rejection: opportunity to prolong kidney allograft survival
Natavudh Townamchai 1 2 3, Yingyos Avihingsanon 1 2 3
Affiliations expand
PMID: 36250450 DOI: 10.1097/MNH.0000000000000843
Abstract
Purpose of review: Antibody-mediated rejection (ABMR) is an important barrier to achieve long-term kidney allograft survival. Human leukocyte antibody (HLA)-incompatibility and ABO-incompatibility are the two main mechanisms of ABMR. Nevertheless, the advances in managing ABMR have changed the paradigm for kidney transplantation. This review aimed to emphasize the HLA-incompatibility and ABO-incompatibility kidney transplant and update the management of ABMR.

Recent findings: HLA-incompatibility kidney transplantation is a strong risk factor for ABMR. Donor-specific antibody (DSA) is a surrogate biomarker that prevents long-term allograft survival. The standard treatment for ABMR has unfavorable results. New drugs that target the B cell are a promising approach to treat ABMR. In the past, ABO-incompatibility kidney donor was an absolute contraindication but now, it is widely accepted as an alternative organ resource. The advancement of ABO antibody removal and B-cell depletion therapy has been successfully developed. ABO isoagglutination remains the main biomarker for monitoring ABMR during the transplantation process. C4d staining without inflammation of the kidney allograft is the marker for the accommodation process.

Summary: With the shortage of organ donors, transplant experts have expanded the organ resources and learned how to overcome the immunological barriers by using novel biomarkers and developing new treatments that support long-term graft survival.



(49267) 부산광역시 서구 감천로(장기려로) 262 고신대학교 의과대학 / 사무팀 Tel. 051-990-6406 Fax. 051-241-5458 / 교학관리팀 Tel. 051-990-6600 Fax. 051-241-0145
Copyright © www.kucm.ac.kr All rights reserved.
^